Pathophysiological targets for non-pharmacological treatment of migraine

Gianluca Coppola, Cherubino Di Lorenzo, Mariano Serrao, Vincenzo Parisi, J. Schoenen, Francesco Pierelli

Research output: Contribution to journalReview article

Abstract

Background Migraine is the most prevalent neurological disorder worldwide and ranked sixth among all diseases in years lived with disability. Overall preventive anti-migraine therapies have an effect in one patient out of two at the most, many of them being endowed with disabling adverse effects. No new disease-modifying drugs have come into clinical practice since the application to migraine of topiramate and botulinum toxin, the latter for its chronic form. There is thus clearly a need for more effective treatments that are devoid of, or have acceptable side effects. In recent years, scientific progress in migraine research has led to substantial changes in our understanding of the pathophysiology of migraine and paved the way for novel non-drug pathophysiological-targeted treatment strategies. Overview Several such non-drug therapies have been tested in migraine, such as oxidative phosphorylation enhancers, diets and non-invasive central or peripheral neurostimulation. All of them are promising for preventive migraine treatment and are quasi-devoid of side effects. Their advantage is that they can in theory be selected for individual patients according to their pathophysiological profile and they can (and probably should) be combined with the classical pharmacological armamentarium. Conclusion We will review here how knowledge of the functional anatomy and physiology of migraine mechanisms holds the key for more specific and effective non-pharmacological treatments.

Original languageEnglish
Pages (from-to)1103-1111
Number of pages9
JournalCephalalgia
Volume36
Issue number12
DOIs
Publication statusPublished - Oct 1 2016

Fingerprint

Migraine Disorders
Therapeutics
Botulinum Toxins
Oxidative Phosphorylation
Nervous System Diseases
Anatomy
Pharmacology
Diet
Research
Pharmaceutical Preparations

Keywords

  • diets
  • migraine pathophysiology
  • neurostimulation
  • Non-pharmacological treatment
  • nutraceuticals

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Pathophysiological targets for non-pharmacological treatment of migraine. / Coppola, Gianluca; Di Lorenzo, Cherubino; Serrao, Mariano; Parisi, Vincenzo; Schoenen, J.; Pierelli, Francesco.

In: Cephalalgia, Vol. 36, No. 12, 01.10.2016, p. 1103-1111.

Research output: Contribution to journalReview article

Coppola, Gianluca ; Di Lorenzo, Cherubino ; Serrao, Mariano ; Parisi, Vincenzo ; Schoenen, J. ; Pierelli, Francesco. / Pathophysiological targets for non-pharmacological treatment of migraine. In: Cephalalgia. 2016 ; Vol. 36, No. 12. pp. 1103-1111.
@article{17ae5b1fe0ae45ca905dcd0cad26a412,
title = "Pathophysiological targets for non-pharmacological treatment of migraine",
abstract = "Background Migraine is the most prevalent neurological disorder worldwide and ranked sixth among all diseases in years lived with disability. Overall preventive anti-migraine therapies have an effect in one patient out of two at the most, many of them being endowed with disabling adverse effects. No new disease-modifying drugs have come into clinical practice since the application to migraine of topiramate and botulinum toxin, the latter for its chronic form. There is thus clearly a need for more effective treatments that are devoid of, or have acceptable side effects. In recent years, scientific progress in migraine research has led to substantial changes in our understanding of the pathophysiology of migraine and paved the way for novel non-drug pathophysiological-targeted treatment strategies. Overview Several such non-drug therapies have been tested in migraine, such as oxidative phosphorylation enhancers, diets and non-invasive central or peripheral neurostimulation. All of them are promising for preventive migraine treatment and are quasi-devoid of side effects. Their advantage is that they can in theory be selected for individual patients according to their pathophysiological profile and they can (and probably should) be combined with the classical pharmacological armamentarium. Conclusion We will review here how knowledge of the functional anatomy and physiology of migraine mechanisms holds the key for more specific and effective non-pharmacological treatments.",
keywords = "diets, migraine pathophysiology, neurostimulation, Non-pharmacological treatment, nutraceuticals",
author = "Gianluca Coppola and {Di Lorenzo}, Cherubino and Mariano Serrao and Vincenzo Parisi and J. Schoenen and Francesco Pierelli",
year = "2016",
month = "10",
day = "1",
doi = "10.1177/0333102415620908",
language = "English",
volume = "36",
pages = "1103--1111",
journal = "Cephalalgia",
issn = "0333-1024",
publisher = "SAGE Publications Ltd",
number = "12",

}

TY - JOUR

T1 - Pathophysiological targets for non-pharmacological treatment of migraine

AU - Coppola, Gianluca

AU - Di Lorenzo, Cherubino

AU - Serrao, Mariano

AU - Parisi, Vincenzo

AU - Schoenen, J.

AU - Pierelli, Francesco

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Background Migraine is the most prevalent neurological disorder worldwide and ranked sixth among all diseases in years lived with disability. Overall preventive anti-migraine therapies have an effect in one patient out of two at the most, many of them being endowed with disabling adverse effects. No new disease-modifying drugs have come into clinical practice since the application to migraine of topiramate and botulinum toxin, the latter for its chronic form. There is thus clearly a need for more effective treatments that are devoid of, or have acceptable side effects. In recent years, scientific progress in migraine research has led to substantial changes in our understanding of the pathophysiology of migraine and paved the way for novel non-drug pathophysiological-targeted treatment strategies. Overview Several such non-drug therapies have been tested in migraine, such as oxidative phosphorylation enhancers, diets and non-invasive central or peripheral neurostimulation. All of them are promising for preventive migraine treatment and are quasi-devoid of side effects. Their advantage is that they can in theory be selected for individual patients according to their pathophysiological profile and they can (and probably should) be combined with the classical pharmacological armamentarium. Conclusion We will review here how knowledge of the functional anatomy and physiology of migraine mechanisms holds the key for more specific and effective non-pharmacological treatments.

AB - Background Migraine is the most prevalent neurological disorder worldwide and ranked sixth among all diseases in years lived with disability. Overall preventive anti-migraine therapies have an effect in one patient out of two at the most, many of them being endowed with disabling adverse effects. No new disease-modifying drugs have come into clinical practice since the application to migraine of topiramate and botulinum toxin, the latter for its chronic form. There is thus clearly a need for more effective treatments that are devoid of, or have acceptable side effects. In recent years, scientific progress in migraine research has led to substantial changes in our understanding of the pathophysiology of migraine and paved the way for novel non-drug pathophysiological-targeted treatment strategies. Overview Several such non-drug therapies have been tested in migraine, such as oxidative phosphorylation enhancers, diets and non-invasive central or peripheral neurostimulation. All of them are promising for preventive migraine treatment and are quasi-devoid of side effects. Their advantage is that they can in theory be selected for individual patients according to their pathophysiological profile and they can (and probably should) be combined with the classical pharmacological armamentarium. Conclusion We will review here how knowledge of the functional anatomy and physiology of migraine mechanisms holds the key for more specific and effective non-pharmacological treatments.

KW - diets

KW - migraine pathophysiology

KW - neurostimulation

KW - Non-pharmacological treatment

KW - nutraceuticals

UR - http://www.scopus.com/inward/record.url?scp=84992327063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992327063&partnerID=8YFLogxK

U2 - 10.1177/0333102415620908

DO - 10.1177/0333102415620908

M3 - Review article

VL - 36

SP - 1103

EP - 1111

JO - Cephalalgia

JF - Cephalalgia

SN - 0333-1024

IS - 12

ER -